Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Rituximab for rheumatoid arthritis

Esta versión no es la más reciente

ver la versión actual 20 enero 2015

Información

DOI:
https://doi.org/10.1002/14651858.CD007356Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 08 octubre 2008see what's new
Tipo:
  1. Intervention
Etapa:
  1. Protocol
Grupo Editorial Cochrane:

  1. Grupo Cochrane de Salud musculoesquelética

Copyright:
  1. Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Maria Angeles Lopez‐Olivo

    General Internal Medicine, Ambulatory Treatment and Emergency Care, The University of Texas, M.D. Anderson Cancer Center, Houston, USA

  • Matxalen Amezaga

    General Internal Medicine, Ambulatory Treatment and Emergency Care, The University of Texas, M.D. Anderson Cancer Center, Houston, USA

  • Lynda McGahan

    HTA Directorate, Canadian Agency for Drugs and Technologies in Health (CADTH), Ottawa, Canada

  • Maria E Suarez‐Almazor

    Correspondencia a: General Internal Medicine, Ambulatory Treatment and Emergency Care, The University of Texas, M.D. Anderson Cancer Center, Houston, USA

    [email protected]

Contributions of authors

Link with editorial base and co‐ordinate contributions from co‐authors (MSA)
Draft protocol (MLO, MAU, LM, MSA)
Run search (LF)
Identify relevant titles and abstracts from searches (MLO, MAU)
Obtain copies of trials (MLO)
Selection of trials (MLO, MAU, MSA)
Extract data from trials (MLO, MAU, LM)
Enter data into RevMan (MLO)
Carry out analysis (MLO, MSA)
Interpret data (MLO, MAU, LM, MSA)
Draft final review (MSA with contributions from all)
Update review (MLO, LM, MSA)

Sources of support

Internal sources

  • University of Texas. MD Anderson Cancer Center, USA.

External sources

  • No sources of support supplied

Declarations of interest

Dr. Suarez‐Almazor is the recipient of a K24 career award from the National Institute for Musculoskeletal and Skin Disorders. She is also the Director of the Houston Centre for Education and Research on Therapeutics, funded by the Agency for Healthcare Research and Quality (AHRQ).

Acknowledgements

The authors would like to thank Louise Falzon who kindly have contributed to developing the searches for this protocol.

Version history

Published

Title

Stage

Authors

Version

2015 Jan 20

Rituximab for rheumatoid arthritis

Review

Maria Angeles Lopez‐Olivo, Matxalen Amezaga Urruela, Lynda McGahan, Eduardo N Pollono, Maria E Suarez‐Almazor

https://doi.org/10.1002/14651858.CD007356.pub2

2008 Oct 08

Rituximab for rheumatoid arthritis

Protocol

Maria Angeles Lopez‐Olivo, Matxalen Amezaga, Lynda McGahan, Maria E Suarez‐Almazor

https://doi.org/10.1002/14651858.CD007356

Keywords

MeSH

Medical Subject Headings (MeSH) Keywords

Medical Subject Headings Check Words

Humans;

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.